157 related articles for article (PubMed ID: 38076968)
1. The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across species.
González Dalmasy JM; Fitzsimmons CM; Frye WJE; Perciaccante AJ; Jewell CP; Jenkins LM; Batista PJ; Robey RW; Gottesman MM
bioRxiv; 2023 Nov; ():. PubMed ID: 38076968
[TBL] [Abstract][Full Text] [Related]
2. The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across species.
González Dalmasy JM; Fitzsimmons CM; Frye WJE; Perciaccante AJ; Jewell CP; Jenkins LM; Batista PJ; Robey RW; Gottesman MM
Chem Biol Interact; 2024 May; 394():110989. PubMed ID: 38574836
[TBL] [Abstract][Full Text] [Related]
3. The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors.
Robey RW; Fitzsimmons CM; Guiblet WM; Frye WJE; González Dalmasy JM; Wang L; Russell DA; Huff LM; Perciaccante AJ; Ali-Rahmani F; Lipsey CC; Wade HM; Mitchell AV; Maligireddy SS; Terrero D; Butcher D; Edmondson EF; Jenkins LM; Nikitina T; Zhurkin VB; Tiwari AK; Piscopio AD; Totah RA; Bates SE; Arda HE; Gottesman MM; Batista PJ
Mol Cancer Ther; 2024 Apr; 23(4):464-477. PubMed ID: 38151817
[TBL] [Abstract][Full Text] [Related]
4. METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl
Russell DA; Chau MK; Shi Y; Levasseur IN; Maldonato BJ; Totah RA
Drug Metab Dispos; 2023 Aug; 51(8):1024-1034. PubMed ID: 37137720
[No Abstract] [Full Text] [Related]
5. Defining the elusive oncogenic role of the methyltransferase TMT1B.
Denford SE; Wilhelm BT
Front Oncol; 2023; 13():1211540. PubMed ID: 37456227
[TBL] [Abstract][Full Text] [Related]
6. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
Vinodhkumar R; Song YS; Devaki T
Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.
Luchenko VL; Litman T; Chakraborty AR; Heffner A; Devor C; Wilkerson J; Stein W; Robey RW; Bangiolo L; Levens D; Bates SE
Mol Oncol; 2014 Dec; 8(8):1379-92. PubMed ID: 24954856
[TBL] [Abstract][Full Text] [Related]
8. P21-driven multifusion gene system for evaluating the efficacy of histone deacetylase inhibitors by in vivo molecular imaging and for transcription targeting therapy of cancer mediated by histone deacetylase inhibitor.
Hsieh YJ; Hwu L; Chen YC; Ke CC; Chen FD; Wang HE; Lin KP; Yeh HH; Chang CW; Liu RS
J Nucl Med; 2014 Apr; 55(4):678-85. PubMed ID: 24639460
[TBL] [Abstract][Full Text] [Related]
9. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target.
Kawano Y; Nasu K; Li H; Tsuno A; Abe W; Takai N; Narahara H
Hum Reprod; 2011 Sep; 26(9):2486-98. PubMed ID: 21715447
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
[TBL] [Abstract][Full Text] [Related]
11. Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma.
Paoluzzi L; Scotto L; Marchi E; Zain J; Seshan VE; O'Connor OA
Clin Cancer Res; 2010 Jan; 16(2):554-65. PubMed ID: 20068080
[TBL] [Abstract][Full Text] [Related]
12. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
Karthik S; Sankar R; Varunkumar K; Ravikumar V
Biomed Pharmacother; 2014 Apr; 68(3):327-34. PubMed ID: 24485799
[TBL] [Abstract][Full Text] [Related]
13. Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma.
Jimura N; Fujii K; Qiao Z; Tsuchiya R; Yoshimatsu Y; Kondo T; Kanekura T
J Dermatol Sci; 2021 Mar; 101(3):194-201. PubMed ID: 33531202
[TBL] [Abstract][Full Text] [Related]
14. Romidepsin for the treatment of non-Hodgkin's lymphoma.
Yazbeck VY; Grant S
Expert Opin Investig Drugs; 2015; 24(7):965-79. PubMed ID: 25936363
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes.
Jones RB; O'Connor R; Mueller S; Foley M; Szeto GL; Karel D; Lichterfeld M; Kovacs C; Ostrowski MA; Trocha A; Irvine DJ; Walker BD
PLoS Pathog; 2014 Aug; 10(8):e1004287. PubMed ID: 25122219
[TBL] [Abstract][Full Text] [Related]
16. Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m
Zhuang A; Gu X; Ge T; Wang S; Ge S; Chai P; Jia R; Fan X
Cancer Commun (Lond); 2023 Nov; 43(11):1185-1206. PubMed ID: 37466203
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells.
Brazelle W; Kreahling JM; Gemmer J; Ma Y; Cress WD; Haura E; Altiok S
PLoS One; 2010 Dec; 5(12):e14335. PubMed ID: 21179472
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
Li QQ; Hao JJ; Zhang Z; Hsu I; Liu Y; Tao Z; Lewi K; Metwalli AR; Agarwal PK
Int J Oncol; 2016 Jun; 48(6):2591-607. PubMed ID: 27082124
[TBL] [Abstract][Full Text] [Related]
20. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
Takai N; Kawamata N; Gui D; Said JW; Miyakawa I; Koeffler HP
Cancer; 2004 Dec; 101(12):2760-70. PubMed ID: 15536623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
